Modesen Biopharmaceutical

Modesen Biopharmaceutical

默得森生物制药

Modesen Biopharmaceutical

Biotech/Healthcare

Mederson Biopharmaceutical is an API (active pharmaceutical ingredient) manufacturer that uses modern biotechnology, mainly engaged in the R&D, production, and sale of chemical drugs, APIs, and pharmaceutical intermediates. Its products include Orlistat, Fusidic Acid, and Sitagliptin Phosphate.

Latest round: Series A (2017)

Source: ChinaBulls — chinabulls.com

Last updated 2017-10-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.